GemVax&KAEL (082270.KQ) Earnings Analysis

GemVax&KAEL (082270.KQ) has no confirmed upcoming earnings date. Trailing P/E -113.23.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 082270.KQ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 082270.KQ. This page updates as the calendar is published.

082270.KQ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-1942 KRWn/an/an/a
2025-11-12-58 KRWn/an/an/a
2025-08-18-39.74013 KRWn/an/an/a
2025-05-15-222.99772 KRWn/an/an/a
2025-03-21-1,175.95569 KRWn/an/an/a
2024-11-14-205.99999 KRWn/an/an/a
2024-08-1455.68 KRWn/an/an/a

082270.KQ valuation and analyst view

Trailing P/E-113.23
Trailing EPS-91.57226 KRW
Price / book5.46
Dividend yield0.00%
Market cap428.12B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is GemVax&KAEL (082270.KQ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 082270.KQ. This page updates as the calendar is published.

Did 082270.KQ beat earnings last quarter?

Consensus estimate data was not available for 082270.KQ's 2026-03-19 report.

What is 082270.KQ's current P/E ratio and EPS?

082270.KQ trades at a trailing P/E of -113.23 on trailing EPS of -91.57225770674198 KRW.

What do analysts rate 082270.KQ?

082270.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.